A very positive quarterly with minimal cash burn and everything seems on track, even better than predicted with regards to the clinical trials.
All these conferences coming up as previously highlighted by Vintage will be massive exposure in all the key places....the future looks bright.
On Ya Team EMV
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-7
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.95 |
Change
0.110(5.98%) |
Mkt cap ! $166.5M | |||
| Open | High | Low | Value | Volume |
| $1.84 | $1.97 | $1.81 | $231.3K | 123.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $1.91 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 2394 | 1 |
View Market Depth
| Last trade - 16.10pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.95 |
Change
0.110 ( 4.22 %) |
||||
| Open | High | Low | Volume | ||
| $1.83 | $1.97 | $1.81 | 18453 | ||
| Last updated 15.57pm 16/05/2024 ? | |||||
| EMV (ASX) Chart |